Patricia Deverka, MD, MS, MBE is a Senior Research Director at the Center for Medical Technology Policy (CMTP), Her current research responsibilities reflect her broad expertise in comparative effectiveness research and genomics and personalized medicine, including for example CANCERGEN, molecular diagnostics EGD and the CER Institute. Before joining CMTP, Dr. Deverka was on the faculty at the Institute for Pharmacogenomics and Individualized Therapy at the University of North Carolina at Chapel Hill, where her research focused on issues such as coverage and reimbursement and improving the evidence base for pharmacogenomic tests. Earlier in her career, she worked as an outcomes researcher in the pharmaceutical industry and was VP of Scientific Affairs at Medco Health Solutions, where she led several pharmacogenomic-related initiatives. Deverka has a medical degree from the University of Pittsburgh and is board certified in general preventive medicine and public health. She also obtained a Master’s degree in bioethics from the University of Pennsylvania and completed a fellowship at Duke University’s Institute for Genome Sciences and Policy.
